These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 19054590)
1. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan. Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590 [TBL] [Abstract][Full Text] [Related]
2. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer. Bulut I; Meral M; Kaynar H; Pirim I; Bilici M; Gorguner M Lung Cancer; 2009 Nov; 66(2):231-6. PubMed ID: 19246116 [TBL] [Abstract][Full Text] [Related]
3. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963 [TBL] [Abstract][Full Text] [Related]
5. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2. Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337 [TBL] [Abstract][Full Text] [Related]
6. Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2. So T; Takenoyama M; Sugaya M; Yasuda M; Eifuku R; Yoshimatsu T; Osaki T; Yasumoto K Lung Cancer; 2001 Apr; 32(1):39-46. PubMed ID: 11282427 [TBL] [Abstract][Full Text] [Related]
7. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer. Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma. Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749 [TBL] [Abstract][Full Text] [Related]
9. Staging and resection of lung cancer with minimal invasion of the adjacent lobe. Demir A; Gunluoglu MZ; Sansar D; Melek H; Dincer SI Eur J Cardiothorac Surg; 2007 Dec; 32(6):855-8. PubMed ID: 17936002 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer. Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764 [TBL] [Abstract][Full Text] [Related]
13. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327 [TBL] [Abstract][Full Text] [Related]
14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
15. Expression of deltaNp73 predicts poor prognosis in lung cancer. Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Morita M; Funa K; Yasumoto K Clin Cancer Res; 2004 Oct; 10(20):6905-11. PubMed ID: 15501968 [TBL] [Abstract][Full Text] [Related]
16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related]
17. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related]
18. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer]. Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. Miyoshi K; Moriyama S; Kunitomo T; Nawa S J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer. Yu M; Wan Y; Zou Q Clin Biochem; 2008 Jul; 41(10-11):824-30. PubMed ID: 18420035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]